Tulip BioMed, Inc., formerly known as Cell Bio-Systems, Inc. (OTC: CBSI), a developer of medical devices and patented technologies for the living tissue markets, including plastic, cosmetic, and orthopedic surgeries, today announced it has added a significant group of medical industry and business experts to two corporate advisory boards: a Board of Scientific Advisors (BOSA) and a Board of Advisors (BOA).
